ADARx Pharmaceuticals’ $200 Million Series C Financing Round

Sidley Austin represented ADARx Pharmaceuticals in the financing.ADARx Pharmaceuticals, Inc. announced its successful close of an oversubscribed $200 million Series C financing. The proceeds from the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now